Skip to main navigation Skip to search Skip to main content

Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation

  • Eunice L. Kwak
  • , Geoffrey I. Shapiro
  • , Seth M. Cohen
  • , Carlos R. Becerra
  • , Heinz Josef Lenz
  • , Wen Fang Cheng
  • , Wu Chou Su
  • , Meghan Robohn
  • , Florence Le Maulf
  • , Maximilian T. Lobmeyer
  • , Vikram K. Chand
  • , A. John Iafrate

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science